MYCN and neuroblastoma: Importantly, NDRG1 was found to be a positive prognostic factor in neuroblastoma, regardless of the MYCN amplification status, which suggests a functional role of NDRG1 on its own in addition to its role as a marker of N-MYC dysregulation in neuroblastoma [23].